Skip to main content

Peer Review reports

From: High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma

Original Submission
4 Sep 2021 Submitted Original manuscript
5 Oct 2021 Reviewed Reviewer Report
6 Oct 2021 Reviewed Reviewer Report
24 Oct 2021 Author responded Author comments - Meijuan Wu
Resubmission - Version 2
24 Oct 2021 Submitted Manuscript version 2
28 Oct 2021 Reviewed Reviewer Report
15 Nov 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
17 Nov 2021 Editorially accepted
3 Jan 2022 Article published 10.1186/s12885-021-09028-4

You can find further information about peer review here.

Back to article page